<DOC>
	<DOCNO>NCT00737724</DOCNO>
	<brief_summary>The purpose study evaluate compare efficacy immediate antiretroviral therapy versus 2 month defer anti-Tb therapy upon clinical course tuberculosis HIV infection patient AIDS active tuberculosis .</brief_summary>
	<brief_title>Simultaneous Versus Sequential Antiretroviral Therapy ( ARV ) Therapy Mycobacterium Tuberculosis ( MTB ) Treatment</brief_title>
	<detailed_description>AIDS tuberculosis two international national priority public health problem . The best time start antiretroviral therapy patient AIDS active tuberculosis clear , despite guideline regard CD4+ count . The debate surround issue mainly due difficulty among adherence anti-MTb anti-HIV treatment , pharmacological interaction , adverse event relate drug risk inflammatory reconstitution syndrome , especially patient advance HIV infection . Moreover , great debate upon lack knowledge degree immune reconstitution throughout time Mtb induce anti-HIV therapy .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<mesh_term>Antitubercular Agents</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<criteria>HIV infect &lt; 200 CD4+ cells/mL Active pulmonary tuberculosis ( without extrapulmonary involvement ) Meningeal tuberculosis Unable attend 96 wk followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Enzyme-Linked ImmunoSpot</keyword>
	<keyword>Deferred treatment</keyword>
	<keyword>Immune Recovery Inflammatory Syndrome</keyword>
</DOC>